Atrial Strain in Septic Shock

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

Septic shock is a critical condition associated with high mortality. Transthoracic echocardiography is widely used to evaluate cardiac function and guide treatment. Left and right atrial strain (LAS and RAS) measured via speckle tracking echocardiography have shown prognostic value in cardiovascular diseases. However, differences exist between echocardiographic software, leading to challenges in result comparability. This study aims to compare LAS and RAS measurements between ECHOPAC and UWS software, evaluate AutoStrain technology, and assess reproducibility across observers. The study is non-interventional and will use retrospective echocardiographic data from patients treated for septic shock. The findings will contribute to improving measurement standardization in critically ill patients.

Eligibility criteria

Qualifiers

Age: >18 years

Adult patients admitted to critical care for septic shock (SEPSIS-3 definition)

TTE performed as part of medical management

No objection to data usage

Disqualifiers

Pregnancy

Moderate to severe valvular regurgitation/stenosis (>grade 2)

Ventricular or supraventricular tachyarrhythmia (HR >140 bpm) at the time of TTE

Poor echogenicity preventing LAS measurement

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Henri Mondor University Hospital

Collaborator